Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-5241EnglishN2023May11Pharmaceutical SciencesLipid Nanobiotechnology: An Alternative Strategy to Targeted Drug and Vaccine Delivery System and Its Biomedical Applications as Nanomedicine   English0109Ashish S. RamtekeEnglishAshish S. Ramteke, Visvesvaraya National Institute of Technology, Nagpur 440 010, India.https://doi.org/10.31782/IJMPS.2023.13501English Lipid nanoparticles, Liposome, Immunoliposome, Targeted delivery, Vaccine, Nanomedicinehttp://ijcrr.com/abstract.php?article_id=226http://ijcrr.com/article_html.php?did=226

Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-5241EnglishN2023May11Pharmaceutical SciencesRecent Advancements in the Pharmacotherapeutic Perspectives of Potential Anti-Viral Agents       English1013Prachi ShambharkarEnglish Kalyani ThakreEnglish Pooja ChacherkarEnglishKalyani Thakre, Assistant Professor, Department of Pharmaceutics, Shree Sadguru Datta Institute of Pharmacy, Kuhi, Dist. Nagpur, Maharashtra, India.https://doi.org/10.31782/IJMPS.2023.13502EnglishAnti-viral, HIV, Polio, Rhino, Dengue, Influenzahttp://ijcrr.com/abstract.php?article_id=228http://ijcrr.com/article_html.php?did=2281. Moss JA. HIV/AIDS Review. Radiologic technology. 2013;84(3):247-67. 2. J.H. Wu, X.H. Wang, Y.H. Yi, K.H. Lee. A potent anti-HIV chalcone and flavonoids from genus Desmos, Bioorg. Med. Chem. Lett. 13 (2003) 1813-1815. 3. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors: a review for clinicians. JAMA, 1997;277(2):145-53. 4. S. Tewtrakul, S. Subhadhirasakul, J. Puripattanavong, T. Panphadung, HIV-1 protease inhibitory substances from the rhizomes of Boesenbergia pandurata Holtt, Songklanakarin J. Sci. Technol. 25 (4) (2003) 503-508. 5. Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, Modlin JF, Patriarca PA, Sutter RW, Wright PF, Wassilak SG. Expert review on poliovirus immunity and transmission. Risk Analysis. 2013;33(4):544-605. 6. A.M. Ahmed, G.T. Sadiq, N.H. Kareem, M.O. Abdullatif, Inhibitory effects of chalcone on the replication of polio virus in vitro, J. Baghdad Sci. 10 (2) (2013) 319-322. 7. Patick AK. Rhinovirus chemotherapy. Antiviral research. 2006;71(2-3):391-6. 8. H. Ishitsuka, Y.T. Ninomiya, C. Ohsawa, M. Fujiu, Y. Suhara, Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410, Antimicrob. Agents Chemother. 22 (4) (1982) 617- 621. 9. Yin Z, Patel SJ, Wang WL, Wang G, Chan WL, Rao KR, Alam J, Jeyaraj DA, Ngew X, Patel V, Beer D. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead. Bioorganic & medicinal chemistry letters. 2006;16(1):36-9. 10. T.S. Kiat, R. Pippen, R. Yusof, H. Ibrahim, N. Khalid, N.A. Rahman, Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease, Bioorg. Med. Chem. Lett. 16 (2006) 3337-3340. 11. Mahapatra DK. Neuraminidase Inhibitors for Effective Treatment of Influenza. Int J Pharm Res Technol. 2014; 4(1): 22-31. 12. T. Dao, B. Tung, P. Nguyen, P. Thuong, S. Yoo, E. Kim, S. Kim, W. Oh, C-Methylated flavonoids from Cleistocalyx operculatus and their inhibitory effects on novel influenza A (H1N1) neuraminidase, J. Nat. Prod. 73 (2010) 1636-1642. 13. T.T. Dao, P.H. Nguyen, H.S. Lee, E. Kim, J. Park, S.I. Lim, W.K. Oh, Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflate, Bioorg. Med. Chem. Lett. 21 (2011) 294-298. 14. J. Park, H.J. Jeong, Y.M. Kim, S. Park, M. Rho, K.H. Park, Y.B. Ryu, W.S. Lee, Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition, Bioorg. Med. Chem. Lett. 21 (2011) 5602-5604. 15. Scholthof KB. Tobacco mosaic virus: a model system for plant biology. Annu. Rev. Phytopathol.. 2004;42:13-34. 16. Ye Y, Dong W, Liu C, et al. Chalcones from Desmodium podocarpum and Their Anti-Tobacco Mosaic Virus Activity. Chem Nat Compd 2016; 52(3): 409-12.